PO.MCB05.01 · 分子与细胞生物学
核酸酶EXO1在BRCA功能正常的细胞中通过降解新生DNA促进基因组不稳定
The nuclease EXO1 promotes genomic instability by degrading nascent DNA in BRCA-proficient cells
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
基因组不稳定促进癌变。DNA修复基因通常被视为肿瘤抑制因子,因为其失活见于肿瘤中并与癌变相关。BRCA1和BRCA2基因突变见于乳腺癌、卵巢癌及其他癌症。BRCA通路失活导致同源重组DNA修复缺陷,以及在复制应激期间新生DNA的降解。这种降解由包括MRE11和EXO1在内的核酸酶催化,发生于复制应激时形成的两类DNA结构处,即单链DNA(ssDNA)缺口和逆行复制叉,最终导致双链DNA断裂(DSB)的形成。然而,大多数肿瘤的BRCA通路功能正常。在此,我们表明EXO1在相当比例的肿瘤中过表达。EXO1过表达通过其外切核酸酶催化活性,导致新生DNA在ssDNA缺口和逆行叉两处均被降解。重要的是,EXO1介导的新生链降解通过其与MRE11的协作,在BRCA功能正常的细胞中高效发生。这导致DSB形成增加以及对基因毒性药物的超敏感性。因此,我们将EXO1活性升高确定为一种类似于BRCA通路失活的基因组不稳定机制,但相较于BRCA失活,其在肿瘤中更为频繁地发生。
查看英文原文 English abstract
Genomic instability promotes carcinogenesis. DNA repair genes are generally considered tumor suppressors, as their inactivation is observed in tumors and is associated with carcinogenesis. Mutations in BRCA1 and BRCA2 genes are observed in breast, ovarian, and other cancers. BRCA pathway inactivation results in defective homologous recombination DNA repair, as well as in degradation of nascent DNA during replication stress. This degradation is catalyzed by nucleases including MRE11 and EXO1, and occurs at two types of DNA structures which are formed upon replication stress, namely single stranded DNA (ssDNA) gaps and reversed replication forks, eventually causing double strand DNA break (DSB) formation. However, most tumors are BRCA pathway-proficient. Here, we show that EXO1 is overexpressed in a significant proportion of tumors. EXO1 overexpression causes the degradation of nascent DNA at both ssDNA gaps and reversed forks, through its exonuclease catalytic activity. Importantly, EXO1-mediated nascent strand degradation occurs efficiently in BRCA-proficient cells, through its cooperation with MRE11. This results in increased DSB formation and hypersensitivity to genotoxic agents. We thus identify increased EXO1 activity as a mechanism of genomic instability similar to BRCA pathway inactivation, but occurring more frequently in tumors compared to BRCA inactivation.
利益披露 Disclosure
A. Nusawardhana, None..
C. M. Nicolae, None..
G. Moldovan, None.